UK Clinical Diagnostics Market Analysis

UK Clinical Diagnostics Market Analysis

$ 3999

The UK Clinical Diagnostic market was valued at $1.79 Bn in 2022 and is estimated to expand at a CAGR of 4% from 2022-30 and will reach $2.45 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, Omega Diagnostics, Quest Diagnostics, F. Hoffmann-La Roche, LumiraDx,, Thermo Fisher Scientific, Danaher Corporation, and others.

ID: IN10GBHS003 CATEGORY: Healthcare Services GEOGRAPHY: UK AUTHOR: Nandini Shah

Buy Now

UK Clinical Diagnostic Market Executive Summary

The UK Clinical Diagnostic market was valued at $1.79 Bn in 2022 and is estimated to expand at a CAGR of 4% from 2022 to 2030 and will reach $2.45 Bn in 2030. In the UK, the clinical diagnostics market is rapidly expanding, with a high need for improved diagnostic technology and solutions. The market has grown dramatically in recent years, owing to rising chronic illness prevalence, a growing elderly population, rising healthcare costs, and government measures to improve early disease identification. With a surge in demand for diagnostic procedures such as RT-PCR and fast antigen tests, the COVID-19 pandemic has also contributed to the expansion of the UK's clinical diagnostics market. The UK government has also launched a number of measures to expand testing capacity and access to diagnostic testing.

uk clinical diagnostics market analysis

Market Dynamics

Market Growth Drivers

The UK has an aging population, which is increasing the demand for diagnostic tests and healthcare services. According to the Office for National Statistics, the proportion of people aged 65 years and over in the UK has increased from 15% in 1985 to 18% in 2020, and is expected to reach 21% by 2030. Chronic diseases, such as diabetes, cancer, and cardiovascular diseases, are on the rise in the UK. According to the National Health Service, 64% of adults in England are overweight or obese, which can lead to an increased risk of developing chronic diseases. The demand for diagnostic tests for these diseases is expected to drive the growth of the clinical diagnostics market. The availability of advanced technologies for diagnosis is another major growth driver for the UK clinical diagnostics market. These technologies, such as next-generation sequencing and digital pathology, enable faster and more accurate diagnosis of diseases and medical conditions, which is particularly important in the early detection and treatment of cancer. The COVID-19 pandemic has led to an increased demand for diagnostic testing in the UK, which has further fueled the growth of the clinical diagnostics market. According to the UK government, over 200 Mn COVID-19 tests have been carried out in the UK since the start of the pandemic.

Market Restraints

The UK clinical diagnostics market is heavily regulated, and obtaining regulatory approval for new diagnostic tests and technologies can be a lengthy and expensive process. In addition, the UK's departure from the European Union has created additional regulatory challenges for companies that operate across multiple countries. There is a shortage of qualified staff in the UK clinical diagnostics market, particularly in areas such as pathology and laboratory science. This can limit the ability of healthcare providers to deliver diagnostic services, and can also create a bottleneck in the approval process for new diagnostic tests and technologies. The UK clinical diagnostics market is highly competitive, with a large number of companies vying for market share. This can make it difficult for smaller companies to gain a foothold in the market, and can also lead to pricing pressure for established companies.

Competitive Landscape

Key Players

  • Abbott
  • Bio-Rad Laboratories
  • Randox Laboratories
  • Siemens
  • Omega Diagnostics
  • Quest Diagnostics
  • F. Hoffmann-La Roche
  • LumiraDx
  • Thermo Fisher Scientific

Healthcare Policies and Regulatory Landscape

The NHS is the publicly funded healthcare system in the UK and plays a significant role in the clinical diagnostics market. The NHS sets policies and guidelines for the use of diagnostic tests and technologies and also provides reimbursement for certain diagnostic services. The Health and Social Care Act 2012 introduced major reforms to the NHS, including the creation of Clinical Commissioning Groups (CCGs) and the NHS England Commissioning Board. These bodies are responsible for commissioning healthcare services, including diagnostic services, and have a significant impact on the clinical diagnostics market.

Accelerated Access Collaborative (AAC) is a government initiative aimed at speeding up the introduction of innovative diagnostic technologies and treatments into the NHS. The AAC works with industry, regulatory bodies, and healthcare providers to identify and remove barriers to the adoption of new technologies. National Institute for Health and Care Excellence (NICE) is an independent organization that provides guidance and recommendations on the use of healthcare technologies, including diagnostic tests. NICE evaluates the clinical and cost-effectiveness of new technologies and makes recommendations on their use in the NHS.

Reimbursement Scenario

Reimbursement for clinical diagnostics in the UK is primarily provided through the National Health Service (NHS), which is funded by the government and provides healthcare services to UK residents free of charge at the point of delivery. The NHS uses a variety of reimbursement mechanisms to pay for diagnostic tests and services, including:

Payment by Results (PbR): PbR is a payment system that reimburses healthcare providers based on the number and type of services they provide. Under PbR, diagnostic tests are reimbursed according to a fixed tariff that is based on the cost of providing the service.

Diagnostic Imaging Dataset (DID): The DID is a database that collects information on diagnostic imaging tests performed in England. The database is used to monitor and analyze the use of diagnostic imaging tests and is also used to calculate reimbursement for these tests.

National Tariff Payment System (NTPS): The NTPS is a payment system that reimburses healthcare providers for a range of services, including diagnostic tests. The system is designed to promote efficiency and quality in the provision of healthcare services and sets prices for diagnostic tests based on the cost of providing the service.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Clinical Diagnostics Market Segmentation

By Test

  • Lab Test
  • Imaging Test
  • Other Tests

By Product

  • Instruments
  • Reagents
  • Other Products

By End User (Revenue, USD Bn):

  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point-of-care Testing
  • Other End Users

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 13 March 2023

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter